alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
From: reedl@cfu.net

To: E-OHPSCA2713.EBSA

Subject: Comment: RIN 1210-AB44

Date: Wednesday, September 07, 2011 1:01:48 PM

To Whom It May Concern:

I am writing today to ask in the strongest way possible that you rescind the unjust and coercive

mandate that all "contraceptives" and sterilization procedures be covered by private health insurance

with no co-pay to patients. If you do not reverse course I ask you to expand conscience protections for

any organizations that provide individual and group insurance and have moral or religious objections. I

strongly oppose the government forcing free insurance coverage on Americans especially for drugs and

devices that I oppose because some of these can cause an abortion (such as ella and Plan B).

I also ask you to reconsider your definition of religious employer and offer an authentic conscience

protection for any organization and business that has moral or religious objection to providing such

insurance to their employees. This legal mandate clearly violates the spirit of conscience laws which

prohibit government discrimination against those who object to various health services on moral or

religious grounds. The definition of "religious employer" in the regulation is so narrow as to only include

churches, but will still mean that a host of businesses and organizations that have conscience objections

will be required to choose between either violating their conscience or not being able to offer employees

health insurance.

Please protect the conscience rights of insurers, providers and people like me who object to being

forced by the federal government to offer or subsidize contraceptives and sterilization services, especially

when some of these drugs can take the life of early unborn children. No Americans should be forced by

the federal government to essentially subsidize services they object to. I again urge you in the strongest

way possible to reverse course and remove contraceptives and sterilizations from the list of mandatory

preventive services.

Sincerely,

Lawrence Reed

Cedar Falls, IA 50613
# NAVCENT hosts final planning conference for IMX 19

/ Published July 19, 2019
MANAMA, Bahrain, 

                Rear Adm. Curt Renshaw, deputy commander, U.S. Naval Forces Central Command, addresses senior military leadership from countries participating in International Maritime Exercise (IMX) 19 during the IMX 19 final planning conference. IMX 19 is the world's most inclusive maritime exercise, designed to strengthen relationships, foster interoperability among supporting forces, and enhance maritime security operations, mine countermeasures (MCM), and maritime infrastructure capabilities in the U.S. 5th Fleet area of operations. (U.S. Navy photo by Mass Communication Specialist 1st Class Jason Abrams/Released)            

                IMX 19            

SHARE IMAGE:

Download Image

Image Details

Photo By: Petty Officer 1st Class Jason Ab

VIRIN: 190715-N-EQ038-102
Filed Pursuant To Rule 433, Registration No. 333-195039








Dated Monday, May 16, 2016





POWERNOTES Issued by CATERPILLAR FINANCIAL SERVICES CORPORATION.





For the Period: 5/16/2016 to 5/23/2016


CouponInterestMaturityCallableSurvivor's OptionPriceCUSIP1.500%Semi-Annual(†††)5/15/202011/15/2016Yes§100.0014912HRY8





Expected Trade Date - Monday, May 23, 2016





Expected Settlement Date - Thursday, May 26, 2016





(†††)First Payment date 11/15/2016





§ The limit for any individual deceased owner or beneficial interest is $200,000 per calendar year. Limit in aggregate per calendar year is 1% of outstanding principal amount of PowerNotes as of the end of the most recent fiscal year. For complete details, see the prospectus .





Callable at 100% beginning on the call date above and semi-annual thereafter with 30 days notice.





Caterpillar Financial Services Corporation has filed a registration statement (including prospectus) with the SEC for the offering to which this communication relates. Before you invest, you should read the prospectus in that registration statement and the other documents Caterpillar Financial Services Corporation has filed with the SEC for more complete information about Caterpillar Financial Services Corporation and this offering. You may get these documents for free by visiting EDGAR on the SEC web site at www.sec.gov. Alternatively, Caterpillar Financial Services Corporation, any underwriter or any dealer participating in the offering will arrange to send you the prospectus if you request it by calling (800) 289-6689.








All offerings are subject to prior sale.





Under no circumstances shall this information constitute an offer to sell, nor shall there be any sale of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such jurisdiction.
From: paulh950@gmail.com

To: E-OHPSCA2713.EBSA

Subject: Comment: RIN 1210-AB44

Date: Wednesday, September 07, 2011 12:58:17 PM

To Whom It May Concern:

I am writing today to ask in the strongest way possible that you rescind the unjust and coercive

mandate that all "contraceptives" and sterilization procedures be covered by private health insurance

with no co-pay to patients. If you do not reverse course I ask you to expand conscience protections for

any organizations that provide individual and group insurance and have moral or religious objections. I

strongly oppose the government forcing free insurance coverage on Americans especially for drugs and

devices that I oppose because some of these can cause an abortion (such as ella and Plan B).

I also ask you to reconsider your definition of religious employer and offer an authentic conscience

protection for any organization and business that has moral or religious objection to providing such

insurance to their employees. This legal mandate clearly violates the spirit of conscience laws which

prohibit government discrimination against those who object to various health services on moral or

religious grounds. The definition of "religious employer" in the regulation is so narrow as to only include

churches, but will still mean that a host of businesses and organizations that have conscience objections

will be required to choose between either violating their conscience or not being able to offer employees

health insurance.

Please protect the conscience rights of insurers, providers and people like me who object to being

forced by the federal government to offer or subsidize contraceptives and sterilization services, especially

when some of these drugs can take the life of early unborn children. No Americans should be forced by

the federal government to essentially subsidize services they object to. I again urge you in the strongest

way possible to reverse course and remove contraceptives and sterilizations from the list of mandatory

preventive services.

Sincerely,

Paul Hamilton

Fort Lauderdale, FL 33321
No. 661.

#### Mississippi et al. *v.*Meredith.

On petition for writ of certiorari to the United States Court of Appeals for the Fifth Circuit. The motion of *John C. Satterfield*for leave to withdraw his appearance as counsel for the petitioners is granted.
II

107TH CONGRESS

1ST SESSION S. 1304

To amend title XVIII of the Social Security Act to provide for coverage

under the medicare program of oral drugs to reduce serum phosphate

levels in dialysis patients with end-stage renal disease.

IN THE SENATE OF THE UNITED STATES

AUGUST 2, 2001

Mr. KERRY introduced the following bill; which was read twice and referred

to the Committee on Finance

A BILL

To amend title XVIII of the Social Security Act to provide

for coverage under the medicare program of oral drugs

to reduce serum phosphate levels in dialysis patients

with end-stage renal disease.

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled,

3 SECTION 1. MEDICARE COVERAGE OF ORAL DRUGS TO RE4 DUCE SERUM PHOSPHATE LEVELS IN DIALY5 SIS PATIENTS WITH END-STAGE RENAL DIS6 EASE.

7 (a) COVERAGE.—Section 1861(s)(2) of the Social Se8 curity Act (42 U.S.C. 1395x(s)(2)), as amended by section
2

•S 1304 IS

1 105(a) of the Medicare, Medicaid, and SCHIP Benefits

2 Improvement and Protection Act of 2000 (114 Stat.

3 2763A–471), as enacted into law by section 1(a)(6) of

4 Public Law 106–554, is amended—

5 (1) in subparagraph (U), by striking ‘‘and’’ at

6 the end;

7 (2) in subparagraph (V), by inserting ‘‘and’’ at

8 the end; and

9 (3) by adding at the end the following new sub10 paragraph:

11 ‘‘(W) an oral drug that—

12 ‘‘(i) is approved by the Food and Drug Ad13 ministration;

14 ‘‘(ii) may be dispensed only upon a pre15 scription; and

16 ‘‘(iii) is furnished to a dialysis patient with

17 end-stage renal disease to prevent dietary sub18 stances from being absorbed into the blood19 stream which are harmful and are not ade20 quately removed by dialysis;’’.

21 (b) EFFECTIVE DATE.—The amendments made by

22 subsection (a) shall apply to drugs furnished on or after

23 the date that is 90 days after the date of enactment of

24 this Act.

Æ
Here's how you know
 **Official websites use .mil** .mil
 **Secure .mil websites use HTTPS** lock () https://


Skip to main content (Press Enter).
 Toggle navigation
            
            U.S. Central Command
                CENTCOM
        Search
                    Search CENTCOM:
                        Search
                Search CENTCOM:
                    Search
    Home

    ABOUT US
    
        COMMAND PRIORITIES

    LEADERSHIP

    COMPONENT COMMANDS

    HISTORY

    POSTURE STATEMENT

    CENTCOM AOR
    
        CENTCOM COALITION

    OPERATIONS AND EXERCISES
    
        USMTM

    CONTACT
    
        OPERATIONAL CONTRACT SUPPORT

    COMMUNITY RELATIONS

    THEATRE MEDICAL CLEARANCE

    INNOVATION VENDOR PORTAL

    MILITARY MEMBER INNOVATION PORTAL

    MEDIA
    
        SOCIAL MEDIA

    NEWS ARTICLES

    PRESS RELEASES

    STATEMENTS

    IMAGERY

    VIDEOS

    TRANSCRIPTS

    VISITORS AND PERSONNEL
    
        FAMILY CENTER

    FAMILY READINESS

    CENTCOM WEBMAIL

    SOCIAL MEDIA SECURITY

    ACCOUNTABILITY

    EMERGENCY PREPAREDNESS

    USCENTCOM UNCLASSIFIED REGULATIONS

    FOIA LIBRARY

    INNOVATION OASIS

    WELCOME GUIDE  Search
 Search
 All Images All ImagesCommunity RelationsOtherPreviousCommanders
 Upload Date Upload DatePhoto DateTitle
  Share
  
 Small () Medium () Full Size (1.27 MB)
 Photo Gallery
 About UsCommand PrioritiesLeadershipComponent
   CommandsHistoryPosture Statement
   Area of
   ResponsibilityCENTCOM Coalition
   Operations And
   ExercisesOperation Inherent
   ResolveResolute Support
   MediaSocial MediaNews ArticlesPress ReleasesVideo And Imagery
   Visitors And
   PersonnelFamily ReadinessCENTCOM WebmailSocial MediaSecurityAccountabilityEmergency
   Preparedness
   ContactCommunity Relations
                    Stay Connected
                
                Privacy & Security  Inspector General  FOIA  Privacy Act
            

Hosted by Defense Media Activity - WEB.mil
Exhibit
32




CERTIFICATION
PURSUANT TO


SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002




In
connection with the Quarterly Report on Form 10-Q of First Robinson Financial
Corporation (the “Company”) for the quarterly period ending September 30, 2010
as filed with the Securities and Exchange Commission on the date of this
Certification (the “Report”), we, Rick L. Catt, Chief Executive Officer and
Jamie E. McReynolds, Chief Financial Officer of the Company, certify, pursuant
to section 906 of the Sarbanes-Oxley Act of 2002, that:




(1)
            the
      Report fully complies with the requirements of section 13(a) or 15(d) of
      the Securities Exchange Act of 1934;
and




(2)
            the
      information contained in the Report fairly presents, in all material
      respects, the financial condition and result of operations of the
      Company.




A signed
original of this written statement required by Section 906, or another document
authenticating, acknowledging or otherwise adopting the signature that appears
in typed form within the electronic version of the written statement required by
Section 906, has been provided to First Robinson Financial Corporation and will
be retained by First Robinson Financial Corporation and furnished to the
Securities and Exchange Commission or its staff upon request.





By:/s/
      Rick L. Catt
                  
                  By: /s/ Jamie E.
  McReynoldsName: Rick
      L. Catt
                  
                  Name: Jamie
      E. McReynoldsChief
      Executive Officer
                  
                  Chief
      Financial OfficerNovember
      12, 2010
                  
                  November
      12, 2010
Index of Supporting Information For:

CMS-1600-P: Revisions to Payment Policies under the Physician Fee Schedule and Other 

Revisions to Part B for CY 2014

Title of Document Confidential 

info or 

proprietary

data?

Social Security Act, Section 1833 No

Social Security Act, Section 1834 No

Social Security Act, Section 1861 No

Social Security Act, Section 1848 No

Middle Class Tax Relief and Job Creation 

Act of 2012 (Pub.L. 112–96)

No

Balanced Budget Act of 1997 (Pub.L. 105–

33)

No

American Taxpayer Relief Act of 2012 

(Pub.L. 112–240)

No

42 C.F.R. 410 No
From: cravertp@hotmail.com

To: E-OHPSCA2713.EBSA

Subject: Comment: RIN 1210-AB44

Date: Wednesday, September 07, 2011 12:43:34 PM

To Whom It May Concern:

I am writing today to ask in the strongest way possible that you rescind the unjust and coercive

mandate that all "contraceptives" and sterilization procedures be covered by private health insurance

with no co-pay to patients. If you do not reverse course I ask you to expand conscience protections for

any organizations that provide individual and group insurance and have moral or religious objections. I

strongly oppose the government forcing free insurance coverage on Americans especially for drugs and

devices that I oppose because some of these can cause an abortion (such as ella and Plan B).

I also ask you to reconsider your definition of religious employer and offer an authentic conscience

protection for any organization and business that has moral or religious objection to providing such

insurance to their employees. This legal mandate clearly violates the spirit of conscience laws which

prohibit government discrimination against those who object to various health services on moral or

religious grounds. The definition of "religious employer" in the regulation is so narrow as to only include

churches, but will still mean that a host of businesses and organizations that have conscience objections

will be required to choose between either violating their conscience or not being able to offer employees

health insurance.

Please protect the conscience rights of insurers, providers and people like me who object to being

forced by the federal government to offer or subsidize contraceptives and sterilization services, especially

when some of these drugs can take the life of early unborn children. No Americans should be forced by

the federal government to essentially subsidize services they object to. I again urge you in the strongest

way possible to reverse course and remove contraceptives and sterilizations from the list of mandatory

preventive services.

Sincerely,

Tom Craver

Batavia, OH 45103
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Energy

###### Federal Energy Regulatory Commission

          - [Project No. 6951-018]

On September 15, 2021, Tallassee Shoals, LLC. filed an application for a new license for the Tallassee Shoals Hydroelectric Project (project) in the above captioned docket. On August 12, 2022, Tallassee Shoals, LLC. filed with the Georgia Environmental Protection Division, a request for water quality certification for the project under section 401(a)(1) of the Clean Water Act.

On September 2, 2022, staff provided the certifying authority with written notice pursuant to 40 CFR 121.6(b) that the applicable reasonable period of time for the state to act on the certification request was one (1) year from the date of receipt of the request, and that the certification requirement for the license would be waived if the certifying authority failed to act by August 12, 2023. Because the state did not act by August 12, 2023, we are notifying you pursuant to 40 CFR 121.9(c), and section 401(a)(1) of the Clean Water Act, 33 U.S.C. 1341(a)(1), that waiver of the certification requirement has occurred.

Dated: August 31, 2023.

Kimberly D. Bose,

Secretary.

[FR Doc. 2023-19293 Filed 9-6-23; 8:45 am]

BILLING CODE 6717-01-P
#### Helen Moore and others, Plaintiffs, v. Allison Oviatt and another, Defendants.

Motion for a new trial denied, with costs on the opinion of the referee.
From: dacey_hodges@hotmail.com

To: E-OHPSCA2713.EBSA

Subject: Comment: RIN 1210-AB44

Date: Wednesday, September 07, 2011 12:10:53 PM

To Whom It May Concern:

I am writing today to ask in the strongest way possible that you rescind the unjust and coercive

mandate that all "contraceptives" and sterilization procedures be covered by private health insurance

with no co-pay to patients. If you do not reverse course I ask you to expand conscience protections for

any organizations that provide individual and group insurance and have moral or religious objections. I

strongly oppose the government forcing free insurance coverage on Americans especially for drugs and

devices that I oppose because some of these can cause an abortion (such as ella and Plan B).

I also ask you to reconsider your definition of religious employer and offer an authentic conscience

protection for any organization and business that has moral or religious objection to providing such

insurance to their employees. This legal mandate clearly violates the spirit of conscience laws which

prohibit government discrimination against those who object to various health services on moral or

religious grounds. The definition of "religious employer" in the regulation is so narrow as to only include

churches, but will still mean that a host of businesses and organizations that have conscience objections

will be required to choose between either violating their conscience or not being able to offer employees

health insurance.

Please protect the conscience rights of insurers, providers and people like me who object to being

forced by the federal government to offer or subsidize contraceptives and sterilization services, especially

when some of these drugs can take the life of early unborn children. No Americans should be forced by

the federal government to essentially subsidize services they object to. I again urge you in the strongest

way possible to reverse course and remove contraceptives and sterilizations from the list of mandatory

preventive services.

Sincerely,

Dacey Hodges

Longview, WA 98632
1 

### Schaeffer, John

From: Lin, Chuantung Sent: Thursday, September 19, 2013 11:49 AM To: Schaeffer, John Cc: Lewis, Paul; Mattheisen, Mike; Williamson, Tracy; C hristian, Myrta Subject: RE: 68610-90-2: Physical-Chemical Properties

Hi John,

My review and comments for this HPV test chemical a re provided below:

1) For the M.P. /Freezing Point endpoint, the sponsor of this HPV 3 test chemical provided a measured val ue of 32 °C (at 1,013 hPa) in the attached submitted docume nt for this endpoint. EPA could accept this value for the M.P. endpoint.

2) For the B.P. endpoint, the sponsor of this HPV 3 te st chemical has concluded that “ esters of fatty acids esterified with alcohols ≥ C3 and having a molecular weight ex ceeding 300 amu have a boiling point > 300 °C, and decompose before boiling.” in its submitted documen t for this endpoint. EPA could accept this estimat ed value
of “>300 °C ” and indicated the test chemical will be decompose d upon boiling above this temperature.

3) For the Vapor Pressure (V.P.) endpoint, the sponso r of this HPV 3 test chemical provided an EPI estim ated value of 0.00000253 Pa (1.90 x 10

- 8 mmHg) at 20 °C . This estimated value is acceptab le to EPA to fulfill the data gap requirement for this endpoint.

4) For the Octanol/Water Partition coefficient (Log Ko w) endpoint, the sponsor of this HPV 3 test chemica l provided two EPI estimated values of 8.09 (by using C8-alkyl diester), and 17.91 (by using C18-alkyl d iester) for this endpoint, respectively. These two estimated v alues (or using Log Kow > 10 data format) are acce ptable to EPA to fulfill the data gap requirement for this en dpoint.

5) For the Water Solubility endpoint, the sponsor of t his HPV 3 test chemical provided a measured value o f <0.15 mg/L @ 20 °C (pH=6.0) for this endpoint. The used method and data are adequate and acceptable to EPA to fulfill the data gap requirement for this test chem ical.

Please let me know if you have any question regardi ng this matter.

Daniel

From: Schaeffer, John Sent: Monday, September 16, 2013 10:51 AM
To: Lin, Chuantung Cc: Lewis, Paul; Mattheisen, Mike Subject: FW: 68610-90-2: Physical-Chemical Properties

Daniel,

I am forwarding for your review several estimates f or BP, MP, LogP, and VP that were submitted to sta nd in for the HPV 3 chemical 2-Butenedioic acid (2E)-, di-C8-18-alkyl esters 68610-90-2

– also for your review is an actual study report fo r WS. All of these endpoints were included as requ ired testing in the
HPV 3 test rule.